Sanjivani Paranteral Ltd

NSE: SANJIVIN · BSE: 531569 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹176.00
Market cap: ₹216.2 Cr
Revenue (annual): ₹68.67 Cr
Net profit (annual): ₹6.79 Cr
P/E (TTM): 20.5×Sector 47.4×
Promoter holding: 31.56%+0.30% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Financial Results 3 Earnings Call 3 Board Meeting Date 3 Promoter Buying 2 Other Announcement 2 Fund Raise 2 Results Update 1 Debt & Borrowing 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

23 Jul 2026 20:12 IST BSE

Capital Structure Change

Sanjivani Paranteral Capital Structure Change

Sanjivani Paranteral's board approved a preferential issue of 5,00,000 fully convertible warrants to a promoter. The issuance aggregates to ₹7.3695 Crore.

Value: ₹7.37 Cr

Read the filing ↗